shutterstock_1147238582_testing
Testing / Shutterstock.com
15 June 2020Asia-PacificSarah Morgan

Roche and Innovent unite in $2bn biospecifics deal

Swiss healthcare company  Roche has partnered with Chinese biotech  Innovent Biologics to develop cell therapies and bispecific antibodies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
Americas
19 March 2020   The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.
Americas
27 February 2020   California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.

More on this story

Americas
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
Americas
19 March 2020   The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.
Americas
27 February 2020   California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.

More on this story

Americas
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
Americas
19 March 2020   The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.
Americas
27 February 2020   California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.